Cystathionine: A Spectroscopic Biomarker for 1p/19q Codeleted Gliomas-Reference-Cited by-同舟云学术

Cystathionine: A Spectroscopic Biomarker for 1p/19q Codeleted Gliomas

Published:2023-09-01 Issue:3 Volume:308 Page:
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Lin Alexander P.¹^ORCID

Affiliation:

1. From the Center for Clinical Spectroscopy, Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, 221 Longwood Ave, BLI236C, Boston, MA 02115.

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.232100

Reference10 articles.

1. World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas

2. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

3. Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402

4. Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

5. The T2-FLAIR mismatch sign as a predictor of IDH-mutant, 1p/19q-noncodeleted lower-grade gliomas: a systematic review and diagnostic meta-analysis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimization and validation of echo times of point-resolved spectroscopy for cystathionine detection in gliomas;Cancer Imaging;2024-09-02

2. Predictive machine learning models based on VASARI features for WHO grading, isocitrate dehydrogenase mutation, and 1p19q co-deletion status: a multicenter study;American Journal of Cancer Research;2024